Nestle Health Science US Holdings, Inc. 3
3 · Aimmune Therapeutics, Inc. · Filed Apr 24, 2020
Insider Transaction Report
Form 3
Holdings
- 11,727,113(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]This Form 3 is being filed to reflect the additions of Nestle US Holdco, Inc. ("Nestle US Holdco") and Societe des Produits Nestle S.A. ("SPN") as Reporting Owners as a result of a corporate reorganization completed December 31, 2018.
- [F2]Held by Nestle Health Science US Holdings, Inc. ("NHS"). Following the corporate reorganization, NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). NIMCO, in turn, is a wholly-owned subsidiary of Nestle US Holdco, which is a wholly-owned subsidiary of SPN. The ultimate parent company of NHS, NIMCO, Nestle US Holdco and SPN is Nestle S.A. ("Nestle"). Following the corporate reorganization, each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.